High content Meloxicam and other new high-end biomedical industrialization projects of Shandong Humon Zhongke Bioengineering Co., Ltd


publish time:

2025-04-14

High content Meloxicam and other new high-end biomedical industrialization projects of Shandong Humon Zhongke Bioengineering Co., Ltd

High content Meloxicam and other new high-end biomedical industrialization projects of Shandong Humon Zhongke Bioengineering Co., Ltd

High content Meloxicam and other new high-end biomedical industrialization projects of Shandong Humon Zhongke Bioengineering Co., Ltd
Total investment of the project: 150 million yuan
Project Overview: The project is jointly invested and constructed by Beijing Zhongke Gene Technology Co., Ltd. and several shareholders of Shouguang. A high standard GMP workshop and supporting facilities of 20432 square meters will be constructed, and 8 GMP production lines and animal disease diagnosis and testing laboratories will be newly purchased, including injection, oral solution, granules, traditional Chinese medicine extraction, and animal yolk antibodies. After 11 years of experiment and innovation, the R&D team has mastered the core technology of 26 veterinary drug brands. The main products are: Meloxicam injection, Cefquinoxime sulfate injection, flunixim meglumine injection, enrofloxacin solution, florfenicol solution, Banqing granules, Qingwen Jiedu oral liquid, duck hepatitis virus yolk antibody, gosling plague virus yolk antibody, bursal disease virus yolk antibody, etc.
Cooperation intention: cooperation, introduction of high-level talents, etc.
Contact information: 15762637699.